News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3 – Oncology Brothers
Photo taken from: Oncology Brothers/X
Feb 14, 2024, 18:13

Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3 – Oncology Brothers

Oncology Brothers made the following post on X:

“Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3: NALIRIFOX vs. Gem/Abrax

  • mOS 11.1mos Vs 9.2mos (HR: 0.83)
  • Cross trial comparison, similar OS w/ FOLFIRINIOX
  • Save liposomal for later lines?”

Source: Oncology Brothers/X

cancer Drugs FDA Oncology Liposomal Irinotecan OncoDaily Oncology Oncology Brothers Pancreatic Cancer Research
Blog
Jul 26, 2024, 19:41
Richi Entrepreneurs launch the first ICEX Programa Desafia in Boston
Blog
Jul 26, 2024, 19:40
CURE funding opportunity - career development awards to promote diversity - NCI Center for Cancer Health Equity
Blog
Jul 26, 2024, 19:40
The World Cancer Congress is the gathering place for the global cancer community - Union for International Cancer Control
Insight
Jul 26, 2024, 19:40
Call for abstracts for ESMO Immuno-Oncology 2024 Congress
Insight
Jul 26, 2024, 19:39
Andrea Necchi: Results from the ECHO-307/KEYNOTE-672 study
Blog
Jul 26, 2024, 19:39
The Weaponization of Professionalism Against Physicians of Color - Florez Lab
Blog
Jul 26, 2024, 19:38
Join the SIOP CONNECT Annual Congress Forum
Blog
Jul 26, 2024, 19:38
Making a difference in the fight against cancer in Kigali - City Cancer Challenge
Blog
Jul 26, 2024, 19:37
Rafeh Naqash: An absolute pleasure working with the JCO Precision Oncology as social media editor
Blog
Jul 26, 2024, 19:37
Chan Cheah: Danish observational study on MAIC of R‐CHOP vs R‐CHOEP for young patients with high‐risk DLBCL
Blog
Jul 26, 2024, 19:34
Arturo LoAIza-Bonilla: Excited to join Total Health as a speaker at the upcoming 2024 ASCO Direct Philadelphia Conference
Insight
Jul 26, 2024, 15:32
Piotr Wysocki: Physical exercise - a new, promising neoadjuvant treatment modality in prostate cancer?